Marta Muñoz-Corcuera

Dr. Marta Muñoz-Corcuera

Universidad Europea, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2009 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
MMMarta Muñoz-Corcuera
Marta Muñoz-Corcuera
GEG. Esparza-Gómez
G. Esparza-Gómez
Miguel Ángel González-MolesMiguel Ángel González-Moles
Miguel Ángel González-Moles
ABA. Bascones-Martínez
A. Bascones-Martínez

1 January 2009 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Closed access
ABA. Bascones-Martinez
A. Bascones-Martinez
MMMarta Muñoz-Corcuera
Marta Muñoz-Corcuera
SNS. Noronha
S. Noronha
PMP. Mota
P. Mota
CBC. Bascones-Ilundain
C. Bascones-Ilundain
JCJ. Campo-Trapero
J. Campo-Trapero
Periodontal diseases are complex bacteria-induced infections characterised by an inflammatory host response to plaque microbiota and their by-products. Most of these microorganisms have virulence factors capable of causing massive tissue destruction both directly, through tissue invasion and the production of harmful substances, or indirectly, by activation of host defense mechanisms, creating an inflammatory infiltrate of potent catabolic activity that can interfere with normal host defense mechanisms. In response to the aggression, host defense mechanisms activate innate and adaptive immune responses. Our aim is to offer a general overview of the main mechanisms involved in the host response to bacterial aggression in periodontitis, such as lipopolysaccharide receptor CD14, complement system, polymorphonuclear neutrophils, antibodies and immunoglobulins.

12 May 2009 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
MMMarta Muñoz-Corcuera
Marta Muñoz-Corcuera
GEG. Esparza-Gómez
G. Esparza-Gómez
Miguel Ángel González-MolesMiguel Ángel González-Moles
Miguel Ángel González-Moles
ABA. Bascones-Martínez
A. Bascones-Martínez

1 July 2015 in Medicina Clinica
Verified
Journal Article
Closed access
ABAntonio Bascones-Martínez
Antonio Bascones-Martínez
MMMarta Muñoz-Corcuera
Marta Muñoz-Corcuera
JBJaime Bascones-Ilundain
Jaime Bascones-Ilundain

1 January 2016 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
MMMarta Muñoz-Corcuera
Marta Muñoz-Corcuera
LRL Ramirez-Martinez-Acitores
L Ramirez-Martinez-Acitores
RLRosa María López-Pintor
Rosa María López-Pintor
ECElisabeth Casañas
Elisabeth Casañas
GHG Hernandez-Vallejo
G Hernandez-Vallejo
Dabigatran is a newly commercialized drug that is replacing other anticoagulants in the prevention of venous thromboembolism, stroke and systemic arterial valve embolism. It acts directly on thrombin presenting in a dynamic and predictable way, which does not require monitoring these patients. Therefore, we consider the need to assess whether their use increases the risk of bleeding involved before any dental treatment. We performed a systematic review with a bibliographic search in PubMed/Medline along with the Cochrane Library. We excluded articles dealing with all anticoagulants other than dabigatran, and works about surgical treatments in anatomical locations other than the oral cavity. We included a total of 13 papers of which 1 was a randomized clinical trial, 9 narrative literature reviews, 1 case series, 2 clinical cases and 1 expert opinion. Because we did not obtain any properly designed clinical trials, we were unable to conduct a meta-analysis. Currently, there is no consensus on the procedure to be followed in patients taking dabigatran. However, all authors agree to treat each case individually in accordance to the risk of embolism, postoperative bleeding and renal function. Also, it is necessary to perform minimally invasive interventions, and take the appropriate local anti-hemolytic measures.

GGGabriela Gil-Abando
Gabriela Gil-Abando
PMPaula Medina
Paula Medina
CSCarolina Signorini
Carolina Signorini
ECElisabeth Casañas
Elisabeth Casañas
NNNatalia Navarrete
Natalia Navarrete
MMMarta Muñoz-Corcuera
Marta Muñoz-Corcuera
Dental anxiety is a matter of interest for the dentist since an anxious patient is a potential source of complications in the dental office. The main objectives of this study are to describe the correlation between dental anxiety levels and the values of physiological parameters related to dental anxiety and to study the evolution of blood pressure and heart rate over time during noninvasive dental treatments, i.e., not requiring local anesthesia. A descriptive, longitudinal, and prospective observational study was designed. The study population consisted of 200 patients who attended a university clinic for dental treatment without local anesthesia. The patients were asked to complete the Corah Dental Anxiety Scale. Afterward, blood pressure and heart rate were measured by means of a digital sphygmomanometer. Blood pressure and heart rate were taken throughout the procedure on four occasions. Most of the patients showed mild dental anxiety (5 [IQR: 3] points on Corah Dental Anxiety Scale). Significant but weak correlations were found between the level of dental anxiety and heart rate (Spearman rho: 0.166 and 0.176; p = 0.019 and 0.013; 3 min before and after treatment, respectively), as well as between the level of dental anxiety and the duration of treatment (Spearman rho: 0.191 3 min; p = 0.007). As for the evolution of physiological parameters, all patients showed a progressive decrease in values at different time points during treatment. When the types of treatment were evaluated separately, it was observed that there were statistically significant differences between them with respect to the level of dental anxiety (p = 0.006).